{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:45:39Z","timestamp":1793879139003,"version":"4.7.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007776","name":"Deanship of Academic Research, University of Jordan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["20200248"],"award-info":[{"award-number":["20200248"]}],"id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019004","name":"Jordan University of Science and Technology Deanship of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.heliyon.2022.e10076","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T02:53:07Z","timestamp":1659581587000},"page":"e10076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antimicrobial use and mortality among intensive care unit patients with bloodstream infections: implications for stewardship programs"],"prefix":"10.1016","volume":"8","author":[{"given":"Mera A.","family":"Ababneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Al Domi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Rababa'h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2022.e10076_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ncp.10232","article-title":"Pathophysiology of Critical Illness and Role of Nutrition","volume":"34","author":"Sharma","year":"2019","journal-title":"Nutr. Clin. Pract."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e10076_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2022.e10076_bib3","series-title":"Sepsis: Just Say Sepsis!","year":"2015"},{"issue":"14","key":"10.1016\/j.heliyon.2022.e10076_bib4","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2016.2691","article-title":"Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis","volume":"315","author":"van Vught","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e10076_bib5","first-page":"479","article-title":"Update on bloodstream infections in ICUs","volume":"18","author":"Timsit","year":"2012","journal-title":"Curr. Opin. Crit. Care"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e10076_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock","volume":"43","author":"Rhodes","year":"2016","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.heliyon.2022.e10076_bib7","series-title":"Septicemia in U.S. Hospitals, 2009: Statistical Brief #122. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Elixhauser","year":"2006"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e10076_bib8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit. Care Med."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e10076_bib9","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1128\/JCM.01537-14","article-title":"Evaluation of the nanosphere Verigene BC-GN assay for direct identification of gram-negative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more-rapid antibiotic interventions","volume":"52","author":"Hill","year":"2014","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e10076_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/phar.1636","article-title":"Infections caused by resistant gram-negative bacteria: epidemiology and management","volume":"35","author":"Kaye","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e10076_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1586\/eri.10.7","article-title":"Management of antibiotic resistance in the intensive care unit setting","volume":"8","author":"Petrosillo","year":"2010","journal-title":"Expert Rev. Anti-infect. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10076_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.21101\/cejph.a4764","article-title":"Mortality rate of ICU patients with the Middle East respiratory syndrome - coronavirus infection at king Fahad hospital, Jeddah, Saudi Arabia","volume":"26","author":"Garout","year":"2018","journal-title":"Cent. Eur. J. Publ. Health"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10076_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/0971-9784.179625","article-title":"Incidence, the microbiological profile of nosocomial infections, and their antibiotic resistance patterns in a high volume Cardiac Surgical Intensive Care Unit","volume":"19","author":"Sahu","year":"2016","journal-title":"Ann. Card Anaesth."},{"issue":"21","key":"10.1016\/j.heliyon.2022.e10076_bib14","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e10076_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jiph.2019.03.014","article-title":"Antimicrobial consumption and bacterial resistance pattern in patients admitted in I.C.U at a tertiary care center","volume":"12","author":"Saxena","year":"2019","journal-title":"J.\u00a0infection Pub. Health"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10076_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12879-017-2529-z","article-title":"Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam","volume":"17","author":"Tran","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e10076_bib17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5578\/mb.68665","article-title":"[Evaluation of infections in intensive care units: a multicentre point-prevalence study]","volume":"53","author":"Ara\u00e7","year":"2019","journal-title":"Mikrobiyoloji Bulteni"},{"key":"10.1016\/j.heliyon.2022.e10076_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13756-018-0451-9","article-title":"Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study","volume":"7","author":"Balkhy","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.heliyon.2022.e10076_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-0711-3-14","article-title":"Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)","volume":"3","author":"Jones","year":"2004","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10076_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2334-6-155","article-title":"Patterns of antimicrobial resistance in a surgical intensive care unit of a university hospital in Turkey","volume":"6","author":"Bayram","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e10076_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3329\/imcj.v4i2.6499","article-title":"Bacterial profile and their antimicrobial resistance pattern in an intensive care unit of a tertiary care hospital of Dhaka","volume":"4","author":"Barai","year":"2010","journal-title":"Ibrahim Med. Coll. J."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e10076_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bjid.2013.07.010","article-title":"Ecology of bloodstream infection and antibiotic resistance in intensive care unit at a tertiary care hospital in North India","volume":"18","author":"Wattal","year":"2014","journal-title":"Braz. J. Infect. Dis.: Off Pub Braz Soc Infect Dis"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10076_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/0049475520977043","article-title":"Bloodstream infections and antibiotic sensitivity pattern in intensive care unit","volume":"51","author":"Chaturvedi","year":"2021","journal-title":"Trop. Doct."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e10076_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/0256-4947.67073","article-title":"Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia","volume":"30","author":"Al Johani","year":"2010","journal-title":"Ann. Saudi Med."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10076_bib26","first-page":"162","article-title":"Pattern of multidrug-resistant bacteria associated with intensive care unit infections in Ibadan, Nigeria","volume":"16","author":"Makanjuola","year":"2018","journal-title":"Ann. Ib. Postgrad. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10076_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/antibiotics10010010","article-title":"Antimicrobial resistance in pathogens isolated from blood cultures: a two-year multicenter hospital surveillance study in Italy","volume":"10","author":"Licata","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e10076_bib28","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/AAC.01538-07","article-title":"Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006","volume":"52","author":"Zhanel","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10076_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","article-title":"Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis","volume":"23","author":"Vincent","year":"2019","journal-title":"Critical Care (London, England"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10076_bib30","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1378\/chest.07-0202","article-title":"Analysis of 30-day mortality for clostridium difficile-associated disease in the ICU setting","volume":"132","author":"Kenneally","year":"2007","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e10076_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e10076_bib32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/cid\/ciy550","article-title":"Antimicrobial stewardship and intensive care unit mortality: a systematic review","volume":"68","author":"Lindsay","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e10076_bib33","series-title":"Risk factors and mortality in patients with sepsis, septic and non septic acute kidney injury in ICU","first-page":"462","volume":"41","author":"Pinheiro","year":"2019"},{"key":"10.1016\/j.heliyon.2022.e10076_bib34","series-title":"International Organizations Unite on Critical Recommendations to Combat Drug-Resistant Infections and Prevent Staggering Number of Deaths Each Year","year":"2019"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10076_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2016.11.001","article-title":"Attributable mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance profile, and antimicrobial therapy","volume":"74","author":"Adrie","year":"2017","journal-title":"J.\u00a0Infect."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022013640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022013640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:10:27Z","timestamp":1772010627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022013640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2405844022013640"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10076","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial use and mortality among intensive care unit patients with bloodstream infections: implications for stewardship programs","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e10076"}}